Recent Finacing
Recent Raise
Ranok develops CHAMP, a chaperone-mediated targeted protein degradation platform that leverages the cellular chaperome to selectively target disease tissues, advancing a cancer program toward clinical trials.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at Ranok Therapeutics.
